Owner Eisai R & D Management Co., Ltd.

Inventors Smith, Terence

Agent Davies Collison Cave

Pub. Number AU-B-2002347365

PCT Number PCT/GB02/05542

PCT Pub. Number WO2003/047577

Priority 0129260.6 06.12.01 GB

Filing date 6 December 2002

Wipo publication date 17 June 2003

Acceptance publication date 19 March 2009

C07D 213/64 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/136 (2006.01) - having the amino group directly attached to the aromatic ring, e.g. benzeneamine

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4409 (2006.01) - only substituted in position 4, e.g. isoniazid, iproniazid

A61K 31/443 (2006.01)

A61K 31/4433 (2006.01)

A61K 31/4436 (2006.01)

A61K 31/4439 (2006.01)

A61K 31/444 (2006.01)

A61K 31/4545 (2006.01)

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/4725 (2006.01)

A61K 31/4745 (2006.01)

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/497 (2006.01)

A61K 31/501 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/5377 (2006.01)

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61K 31/695 (2006.01) - Silicon compounds

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/21 Medicinal preparations containing peptides - Interferons